Division of Gastroenterology, Department of Surgery, Oncological and Gastroenterological Sciences, University of Padua, Padua, Italy.
Research & Development Division, University of Padova, Padova, Italy.
Gut Microbes. 2022 Jan-Dec;14(1):2028366. doi: 10.1080/19490976.2022.2028366.
Ulcerative colitis (UC) is a complex immune-mediated disease in which the gut microbiota plays a central role, and may determine prognosis and disease progression. We aimed to assess whether a specific microbiota profile, as measured by a machine learning approach, can be associated with disease severity in patients with UC. In this prospective pilot study, consecutive patients with active or inactive UC and healthy controls (HCs) were enrolled. Stool samples were collected for fecal microbiota assessment analysis by 16S rRNA gene sequencing approach. A machine learning approach was used to predict the groups' separation. Thirty-six HCs and forty-six patients with UC (20 active and 26 inactive) were enrolled. Alpha diversity was significantly different between the three groups (Shannon index: p-values: active UC vs HCs = 0.0005; active UC vs inactive UC = 0.0273; HCs vs inactive UC = 0.0260). In particular, patients with active UC showed the lowest values, followed by patients with inactive UC, and HCs. At species level, we found high levels of and in inactive UC and active UC, respectively. A specific microbiota profile was found for each group and was confirmed with sparse partial least squares discriminant analysis, a machine learning-supervised approach. The latter allowed us to observe a perfect class prediction and group separation using the complete information (full Operational Taxonomic Unit table), with a minimal loss in performance when using only 5% of features. A machine learning approach to 16S rRNA data identifies a bacterial signature characterizing different degrees of disease activity in UC. Follow-up studies will clarify whether such microbiota profiling are useful for diagnosis and management.
溃疡性结肠炎(UC)是一种复杂的免疫介导性疾病,其中肠道微生物群起着核心作用,并可能决定预后和疾病进展。我们旨在评估通过机器学习方法测量的特定微生物群谱是否与 UC 患者的疾病严重程度相关。在这项前瞻性试点研究中,连续纳入活动期或缓解期 UC 患者和健康对照(HCs)。采集粪便样本进行粪便微生物群评估分析,采用 16S rRNA 基因测序方法。使用机器学习方法预测组间分离。共纳入 36 名 HCs 和 46 名 UC 患者(20 名活动期和 26 名缓解期)。三组间 alpha 多样性差异有统计学意义(Shannon 指数:p 值:活动期 UC 与 HCs=0.0005;活动期 UC 与缓解期 UC=0.0273;HCs 与缓解期 UC=0.0260)。特别是,活动期 UC 患者的数值最低,其次是缓解期 UC 患者和 HCs。在种水平上,我们发现 和 在缓解期 UC 和活动期 UC 中分别呈高水平。我们发现了每个组的特定微生物群谱,并通过稀疏偏最小二乘判别分析(一种机器学习监督方法)进行了确认。后者允许我们使用完整信息(完整操作分类单元表)观察到完美的分类预测和组间分离,当仅使用 5%的特征时,性能损失最小。16S rRNA 数据分析的机器学习方法确定了一个细菌特征,可用于表征 UC 不同疾病活动程度。后续研究将阐明这种微生物组谱是否有助于诊断和管理。